Origins and functions of liver myofibroblasts

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1832, Issue 7, 2013, Pages 948-954

  Lemoinne, Sara ^a,b   Cadoret, Axelle ^a,b   El Mourabit, Haquima ^a,b   Thabut, Dominique ^a,b,c   Housset, Chantal ^a,b,d  

^a SORBONNE UNIVERSITÉ   (France)

^b CENTRE DE RECHERCHE SAINT ANTOINE   (France)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^d HÔPITAL SAINT ANTOINE   (France)

Author keywords

Angiogenesis; Ductular reaction; Hepatic stellate cell; Liver fibrosis; Myofibroblast; Portal fibroblast

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; ANGIOPOIETIN 1; CD34 ANTIGEN; COLLAGEN; DESMIN; JAGGED1; NOTCH3 RECEPTOR; PLATELET DERIVED GROWTH FACTOR BB; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TRANSCRIPTION FACTOR HES 1; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN;

ANGIOGENESIS; CELL DIFFERENTIATION; DISEASE COURSE; LIVER DISEASE; LIVER FIBROSIS; LIVER MYOFIBROBLAST; LIVER REGENERATION; MESENCHYME CELL; MYOFIBROBLAST; NONALCOHOLIC FATTY LIVER; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REVIEW; STELLATE CELL; VASCULARIZATION; HUMAN; LIVER CIRRHOSIS; METABOLISM;

HEPATIC STELLATE CELLS; HUMANS; LIVER CIRRHOSIS; LIVER DISEASES; MYOFIBROBLASTS;

EID: 84877045248     PISSN: 09254439     EISSN: 1879260X     Source Type: Journal    
DOI: 10.1016/j.bbadis.2013.02.019     Document Type: Review

References (95)

1. Hinz B., Phan S.H., Thannickal V.J., Prunotto M., Desmouliere A., Varga J., De Wever O., Mareel M., Gabbiani G. Recent developments in myofibroblast biology: paradigms for connective tissue remodeling. Am. J. Pathol. 2012, 180:1340-1355.
2. Zhou Y., Hagood J.S., Lu B., Merryman W.D., Murphy-Ullrich J.E. Thy-1-integrin alphav beta5 interactions inhibit lung fibroblast contraction-induced latent transforming growth factor-beta1 activation and myofibroblast differentiation. J. Biol. Chem. 2010, 285:22382-22393.
3. Asahina K., Zhou B., Pu W.T., Tsukamoto H. Septum transversum-derived mesothelium gives rise to hepatic stellate cells and perivascular mesenchymal cells in developing mouse liver. Hepatology 2011, 53:983-995.
4. Kent G., Gay S., Inouye T., Bahu R., Minick O.T., Popper H. Vitamin A-containing lipocytes and formation of type III collagen in liver injury. Proc. Natl. Acad. Sci. U. S. A. 1976, 73:3719-3722.
5. Friedman S.L. Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver. Physiol. Rev. 2008, 88:125-172.
6. Maher J.J., McGuire R.F. Extracellular matrix gene expression increases preferentially in rat lipocytes and sinusoidal endothelial cells during hepatic fibrosis in vivo. J. Clin. Invest. 1990, 86:1641-1648.
7. Knook D.L., Seffelaar A.M., de Leeuw A.M. Fat-storing cells of the rat liver. Their isolation and purification. Exp. Cell Res. 1982, 139:468-471.
8. Friedman S.L., Roll F.J. Isolation and culture of hepatic lipocytes, Kupffer cells, and sinusoidal endothelial cells by density gradient centrifugation with Stractan. Anal. Biochem. 1987, 161:207-218.
9. Housset C., Rockey D.C., Bissell D.M. Endothelin receptors in rat liver: lipocytes as a contractile target for endothelin 1. Proc. Natl. Acad. Sci. U. S. A. 1993, 90:9266-9270.
10. Kinnman N., Hultcrantz R., Barbu V., Rey C., Wendum D., Poupon R., Housset C. PDGF-mediated chemoattraction of hepatic stellate cells by bile duct segments in cholestatic liver injury. Lab. Invest. 2000, 80:697-707.
11. Seki E., De Minicis S., Osterreicher C.H., Kluwe J., Osawa Y., Brenner D.A., Schwabe R.F. TLR4 enhances TGF-beta signaling and hepatic fibrosis. Nat. Med. 2007, 13:1324-1332.
12. Corpechot C., Barbu V., Wendum D., Kinnman N., Rey C., Poupon R., Housset C., Rosmorduc O. Hypoxia-induced VEGF and collagen I expressions are associated with angiogenesis and fibrogenesis in experimental cirrhosis. Hepatology 2002, 35:1010-1021.
13. Olsen A.L., Bloomer S.A., Chan E.P., Gaca M.D., Georges P.C., Sackey B., Uemura M., Janmey P.A., Wells R.G. Hepatic stellate cells require a stiff environment for myofibroblastic differentiation. Am. J. Physiol. Gastrointest. Liver Physiol. 2011, 301:G110-G118.
14. Knittel T., Kobold D., Saile B., Grundmann A., Neubauer K., Piscaglia F., Ramadori G. Rat liver myofibroblasts and hepatic stellate cells: different cell populations of the fibroblast lineage with fibrogenic potential. Gastroenterology 1999, 117:1205-1221.
15. Kinnman N., Francoz C., Barbu V., Wendum D., Rey C., Hultcrantz R., Poupon R., Housset C. The myofibroblastic conversion of peribiliary fibrogenic cells distinct from hepatic stellate cells is stimulated by platelet-derived growth factor during liver fibrogenesis. Lab. Invest. 2003, 83:163-173.
16. Tuchweber B., Desmouliere A., Bochaton-Piallat M.L., Rubbia-Brandt L., Gabbiani G. Proliferation and phenotypic modulation of portal fibroblasts in the early stages of cholestatic fibrosis in the rat. Lab. Invest. 1996, 74:265-278.
17. Cassiman D., Libbrecht L., Desmet V., Denef C., Roskams T. Hepatic stellate cell/myofibroblast subpopulations in fibrotic human and rat livers. J. Hepatol. 2002, 36:200-209.
18. Humphreys B.D., Lin S.L., Kobayashi A., Hudson T.E., Nowlin B.T., Bonventre J.V., Valerius M.T., McMahon A.P., Duffield J.S. Fate tracing reveals the pericyte and not epithelial origin of myofibroblasts in kidney fibrosis. Am. J. Pathol. 2010, 176:85-97.
19. Taura K., Miura K., Iwaisako K., Osterreicher C.H., Kodama Y., Penz-Osterreicher M., Brenner D.A. Hepatocytes do not undergo epithelial-mesenchymal transition in liver fibrosis in mice. Hepatology 2010, 51:1027-1036.
20. Scholten D., Osterreicher C.H., Scholten A., Iwaisako K., Gu G., Brenner D.A., Kisseleva T. Genetic labeling does not detect epithelial-to-mesenchymal transition of cholangiocytes in liver fibrosis in mice. Gastroenterology 2010, 139:987-998.
21. Pinzani M. Epithelial-mesenchymal transition in chronic liver disease: fibrogenesis or escape from death?. J. Hepatol. 2011, 55:459-465.
22. Russo F.P., Alison M.R., Bigger B.W., Amofah E., Florou A., Amin F., Bou-Gharios G., Jeffery R., Iredale J.P., Forbes S.J. The bone marrow functionally contributes to liver fibrosis. Gastroenterology 2006, 130:1807-1821.
23. Higashiyama R., Moro T., Nakao S., Mikami K., Fukumitsu H., Ueda Y., Ikeda K., Adachi E., Bou-Gharios G., Okazaki I., Inagaki Y. Negligible contribution of bone marrow-derived cells to collagen production during hepatic fibrogenesis in mice. Gastroenterology 2009, 137:1459-1466. (e1451).
24. Degott C., Zafrani E.S., Callard P., Balkau B., Poupon R.E., Poupon R. Histopathological study of primary biliary cirrhosis and the effect of ursodeoxycholic acid treatment on histology progression. Hepatology 1999, 29:1007-1012.
25. Michalak S., Rousselet M.C., Bedossa P., Pilette C., Chappard D., Oberti F., Gallois Y., Cales P. Respective roles of porto-septal fibrosis and centrilobular fibrosis in alcoholic liver disease. J. Pathol. 2003, 201:55-62.
26. Clouston A.D., Powell E.E., Walsh M.J., Richardson M.M., Demetris A.J., Jonsson J.R. Fibrosis correlates with a ductular reaction in hepatitis C: roles of impaired replication, progenitor cells and steatosis. Hepatology 2005, 41:809-818.
27. Richardson M.M., Jonsson J.R., Powell E.E., Brunt E.M., Neuschwander-Tetri B.A., Bhathal P.S., Dixon J.B., Weltman M.D., Tilg H., Moschen A.R., Purdie D.M., Demetris A.J., Clouston A.D. Progressive fibrosis in nonalcoholic steatohepatitis: association with altered regeneration and a ductular reaction. Gastroenterology 2007, 133:80-90.
28. Nobili V., Carpino G., Alisi A., Franchitto A., Alpini G., De Vito R., Onori P., Alvaro D., Gaudio E. Hepatic progenitor cells activation, fibrosis, and adipokine production in pediatric nonalcoholic fatty liver disease. Hepatology 2012, 56:2142-2153.
29. Nguyen L.N., Furuya M.H., Wolfraim L.A., Nguyen A.P., Holdren M.S., Campbell J.S., Knight B., Yeoh G.C., Fausto N., Parks W.T. Transforming growth factor-beta differentially regulates oval cell and hepatocyte proliferation. Hepatology 2007, 45:31-41.
30. Kinnman N., Housset C. Peribiliary myofibroblasts in biliary type liver fibrosis. Front. Biosci. 2002, 7:d496-d503.
31. Pham Van T., Couchie D., Martin-Garcia N., Laperche Y., Zafrani E.S., Mavier P. Expression of matrix metalloproteinase-2 and -9 and of tissue inhibitor of matrix metalloproteinase-1 in liver regeneration from oval cells in rat. Matrix Biol. 2008, 27:674-681.
32. Chobert M.N., Couchie D., Fourcot A., Zafrani E.S., Laperche Y., Mavier P., Brouillet A. Liver precursor cells increase hepatic fibrosis induced by chronic carbon tetrachloride intoxication in rats. Lab. Invest. 2012, 92:135-150.
33. Wang B., Dolinski B.M., Kikuchi N., Leone D.R., Peters M.G., Weinreb P.H., Violette S.M., Bissell D.M. Role of alphavbeta6 integrin in acute biliary fibrosis. Hepatology 2007, 46:1404-1412.
34. Fourcot A., Couchie D., Chobert M.N., Zafrani E.S., Mavier P., Laperche Y., Brouillet A. Gas6 deficiency prevents liver inflammation, steatohepatitis, and fibrosis in mice. Am. J. Physiol. Gastrointest. Liver Physiol. 2011, 300:G1043-G1053.
35. Omenetti A., Yang L., Li Y.X., McCall S.J., Jung Y., Sicklick J.K., Huang J., Choi S., Suzuki A., Diehl A.M. Hedgehog-mediated mesenchymal-epithelial interactions modulate hepatic response to bile duct ligation. Lab. Invest. 2007, 87:499-514.
36. Bielesz B., Sirin Y., Si H., Niranjan T., Gruenwald A., Ahn S., Kato H., Pullman J., Gessler M., Haase V.H., Susztak K. Epithelial Notch signaling regulates interstitial fibrosis development in the kidneys of mice and humans. J. Clin. Invest. 2010, 120:4040-4054.
37. Chen Y., Zheng S., Qi D., Guo J., Zhang S., Weng Z. Inhibition of Notch signaling by a gamma-secretase inhibitor attenuates hepatic fibrosis in rats. PLoS One 2012, 7:e46512.
38. Fabris L., Cadamuro M., Guido M., Spirli C., Fiorotto R., Colledan M., Torre G., Alberti D., Sonzogni A., Okolicsanyi L., Strazzabosco M. Analysis of liver repair mechanisms in Alagille syndrome and biliary atresia reveals a role for notch signaling. Am. J. Pathol. 2007, 171:641-653.
39. Ryan M.J., Bales C., Nelson A., Gonzalez D.M., Underkoffler L., Segalov M., Wilson-Rawls J., Cole S.E., Moran J.L., Russo P., Spinner N.B., Kusumi K., Loomes K.M. Bile duct proliferation in Jag1/fringe heterozygous mice identifies candidate modifiers of the Alagille syndrome hepatic phenotype. Hepatology 2008, 48:1989-1997.
40. Bertolani C., Sancho-Bru P., Failli P., Bataller R., Aleffi S., DeFranco R., Mazzinghi B., Romagnani P., Milani S., Gines P., Colmenero J., Parola M., Gelmini S., Tarquini R., Laffi G., Pinzani M., Marra F. Resistin as an intrahepatic cytokine: overexpression during chronic injury and induction of proinflammatory actions in hepatic stellate cells. Am. J. Pathol. 2006, 169:2042-2053.
41. Li Z., Dranoff J.A., Chan E.P., Uemura M., Sevigny J., Wells R.G. Transforming growth factor-beta and substrate stiffness regulate portal fibroblast activation in culture. Hepatology 2007, 46:1246-1256.
42. Clouzeau-Girard H., Guyot C., Combe C., Moronvalle-Halley V., Housset C., Lamireau T., Rosenbaum J., Desmouliere A. Effects of bile acids on biliary epithelial cell proliferation and portal fibroblast activation using rat liver slices. Lab. Invest. 2006, 86:275-285.
43. Bosselut N., Housset C., Marcelo P., Rey C., Burmester T., Vinh J., Vaubourdolle M., Cadoret A., Baudin B. Distinct proteomic features of two fibrogenic liver cell populations: hepatic stellate cells and portal myofibroblasts. Proteomics 2010, 10:1017-1028.
44. Kinnman N., Goria O., Wendum D., Gendron M.C., Rey C., Poupon R., Housset C. Hepatic stellate cell proliferation is an early platelet-derived growth factor-mediated cellular event in rat cholestatic liver injury. Lab. Invest. 2001, 81:1709-1716.
45. Beaussier M., Wendum D., Schiffer E., Dumont S., Rey C., Lienhart A., Housset C. Prominent contribution of portal mesenchymal cells to liver fibrosis in ischemic and obstructive cholestatic injuries. Lab. Invest. 2007, 87:292-303.
46. Rosmorduc O., Housset C. Hypoxia: a link between fibrogenesis, angiogenesis, and carcinogenesis in liver disease. Semin. Liver Dis. 2010, 30:258-270.
47. Kawada N., Kristensen D.B., Asahina K., Nakatani K., Minamiyama Y., Seki S., Yoshizato K. Characterization of a stellate cell activation-associated protein (STAP) with peroxidase activity found in rat hepatic stellate cells. J. Biol. Chem. 2001, 276:25318-25323.
48. Xu R., Harrison P.M., Chen M., Li L., Tsui T.Y., Fung P.C., Cheung P.T., Wang G., Li H., Diao Y., Krissansen G.W., Xu S., Farzaneh F. Cytoglobin overexpression protects against damage-induced fibrosis. Mol. Ther. 2006, 13:1093-1100.
49. Rosmorduc O., Wendum D., Corpechot C., Galy B., Sebbagh N., Raleigh J., Housset C., Poupon R. Hepatocellular hypoxia-induced vascular endothelial growth factor expression and angiogenesis in experimental biliary cirrhosis. Am. J. Pathol. 1999, 155:1065-1073.
50. Corpechot C., Barbu V., Wendum D., Chignard N., Housset C., Poupon R., Rosmorduc O. Hepatocyte growth factor and c-Met inhibition by hepatic cell hypoxia: a potential mechanism for liver regeneration failure in experimental cirrhosis. Am. J. Pathol. 2002, 160:613-620.
51. Novo E., Cannito S., Zamara E., Valfre di Bonzo L., Caligiuri A., Cravanzola C., Compagnone A., Colombatto S., Marra F., Pinzani M., Parola M. Proangiogenic cytokines as hypoxia-dependent factors stimulating migration of human hepatic stellate cells. Am. J. Pathol. 2007, 170:1942-1953.
52. Mejias M., Garcia-Pras E., Tiani C., Miquel R., Bosch J., Fernandez M. Beneficial effects of sorafenib on splanchnic, intrahepatic, and portocollateral circulations in portal hypertensive and cirrhotic rats. Hepatology 2009, 49:1245-1256.
53. Coriat R., Gouya H., Mir O., Ropert S., Vignaux O., Chaussade S., Sogni P., Pol S., Blanchet B., Legmann P., Goldwasser F. Reversible decrease of portal venous flow in cirrhotic patients: a positive side effect of sorafenib. PLoS One 2011, 6:e16978.
54. Tugues S., Fernandez-Varo G., Munoz-Luque J., Ros J., Arroyo V., Rodes J., Friedman S.L., Carmeliet P., Jimenez W., Morales-Ruiz M. Antiangiogenic treatment with sunitinib ameliorates inflammatory infiltrate, fibrosis, and portal pressure in cirrhotic rats. Hepatology 2007, 46:1919-1926.
55. Yoshiji H., Kuriyama S., Yoshii J., Ikenaka Y., Noguchi R., Hicklin D.J., Wu Y., Yanase K., Namisaki T., Yamazaki M., Tsujinoue H., Imazu H., Masaki T., Fukui H. Vascular endothelial growth factor and receptor interaction is a prerequisite for murine hepatic fibrogenesis. Gut 2003, 52:1347-1354.
56. Taura K., De Minicis S., Seki E., Hatano E., Iwaisako K., Osterreicher C.H., Kodama Y., Miura K., Ikai I., Uemoto S., Brenner D.A. Hepatic stellate cells secrete angiopoietin 1 that induces angiogenesis in liver fibrosis. Gastroenterology 2008, 135:1729-1738.
57. Lee J.S., Semela D., Iredale J., Shah V.H. Sinusoidal remodeling and angiogenesis: a new function for the liver-specific pericyte?. Hepatology 2007, 45:817-825.
58. Yin C., Evason K.J., Maher J.J., Stainier D.Y. The basic helix-loop-helix transcription factor, heart and neural crest derivatives expressed transcript 2, marks hepatic stellate cells in zebrafish: analysis of stellate cell entry into the developing liver. Hepatology 2012, 56:1958-1970.
59. Kang N., Yaqoob U., Geng Z., Bloch K., Liu C., Gomez T., Billadeau D., Shah V. Focal adhesion assembly in myofibroblasts fosters a microenvironment that promotes tumor growth. Am. J. Pathol. 2010, 177:1888-1900.
60. Aleffi S., Petrai I., Bertolani C., Parola M., Colombatto S., Novo E., Vizzutti F., Anania F.A., Milani S., Rombouts K., Laffi G., Pinzani M., Marra F. Upregulation of proinflammatory and proangiogenic cytokines by leptin in human hepatic stellate cells. Hepatology 2005, 42:1339-1348.
61. Ankoma-Sey V., Wang Y., Dai Z. Hypoxic stimulation of vascular endothelial growth factor expression in activated rat hepatic stellate cells. Hepatology 2000, 31:141-148.
62. Wang Y.Q., Luk J.M., Ikeda K., Man K., Chu A.C., Kaneda K., Fan S.T. Regulatory role of vHL/HIF-1alpha in hypoxia-induced VEGF production in hepatic stellate cells. Biochem. Biophys. Res. Commun. 2004, 317:358-362.
63. Thabut D., Routray C., Lomberk G., Shergill U., Glaser K., Huebert R., Patel L., Masyuk T., Blechacz B., Vercnocke A., Ritman E., Ehman R., Urrutia R., Shah V. Complementary vascular and matrix regulatory pathways underlie the beneficial mechanism of action of sorafenib in liver fibrosis. Hepatology 2011, 54:573-585.
64. Semela D., Das A., Langer D., Kang N., Leof E., Shah V. Platelet-derived growth factor signaling through ephrin-b2 regulates hepatic vascular structure and function. Gastroenterology 2008, 135:671-679.
65. Witek R.P., Yang L., Liu R., Jung Y., Omenetti A., Syn W.K., Choi S.S., Cheong Y., Fearing C.M., Agboola K.M., Chen W., Diehl A.M. Liver cell-derived microparticles activate hedgehog signaling and alter gene expression in hepatic endothelial cells. Gastroenterology 2009, 136:320-330. (e322).
66. Ng C.P., Hinz B., Swartz M.A. Interstitial fluid flow induces myofibroblast differentiation and collagen alignment in vitro. J. Cell Sci. 2005, 118:4731-4739.
67. Deleve L.D., Wang X., Guo Y. Sinusoidal endothelial cells prevent rat stellate cell activation and promote reversion to quiescence. Hepatology 2008, 48:920-930.
68. Novo E., Povero D., Busletta C., Paternostro C., di Bonzo L.V., Cannito S., Compagnone A., Bandino A., Marra F., Colombatto S., David E., Pinzani M., Parola M. The biphasic nature of hypoxia-induced directional migration of activated human hepatic stellate cells. J. Pathol. 2012, 226:588-597.
69. Olaso E., Salado C., Egilegor E., Gutierrez V., Santisteban A., Sancho-Bru P., Friedman S.L., Vidal-Vanaclocha F. Proangiogenic role of tumor-activated hepatic stellate cells in experimental melanoma metastasis. Hepatology 2003, 37:674-685.
70. Van Steenkiste C., Ribera J., Geerts A., Pauta M., Tugues S., Casteleyn C., Libbrecht L., Olievier K., Schroyen B., Reynaert H., van Grunsven L.A., Blomme B., Coulon S., Heindryckx F., De Vos M., Stassen J.M., Vinckier S., Altamirano J., Bataller R., Carmeliet P., Van Vlierberghe H., Colle I., Morales-Ruiz M. Inhibition of placental growth factor activity reduces the severity of fibrosis, inflammation, and portal hypertension in cirrhotic mice. Hepatology 2011, 53:1629-1640.
71. Cao S., Yaqoob U., Das A., Shergill U., Jagavelu K., Huebert R.C., Routray C., Abdelmoneim S., Vasdev M., Leof E., Charlton M., Watts R.J., Mukhopadhyay D., Shah V.H. Neuropilin-1 promotes cirrhosis of the rodent and human liver by enhancing PDGF/TGF-beta signaling in hepatic stellate cells. J. Clin. Invest. 2010, 120:2379-2394.
72. Asai K., Tamakawa S., Yamamoto M., Yoshie M., Tokusashi Y., Yaginuma Y., Kasai S., Ogawa K. Activated hepatic stellate cells overexpress p75NTR after partial hepatectomy and undergo apoptosis on nerve growth factor stimulation. Liver Int. 2006, 26:595-603.
73. Zhu N.L., Asahina K., Wang J., Ueno A., Lazaro R., Miyaoka Y., Miyajima A., Tsukamoto H. Hepatic stellate cell-derived delta-like homolog 1 (DLK1) protein in liver regeneration. J. Biol. Chem. 2012, 287:10355-10367.
74. +/- mice exhibit defective stellate cell activation and abnormal liver regeneration following CCl4 injury. Hepatology 2003, 37:107-117.
75. Ebrahimkhani M.R., Oakley F., Murphy L.B., Mann J., Moles A., Perugorria M.J., Ellis E., Lakey A.F., Burt A.D., Douglass A., Wright M.C., White S.A., Jaffre F., Maroteaux L., Mann D.A. Stimulating healthy tissue regeneration by targeting the 5-HT(2)B receptor in chronic liver disease. Nat. Med. 2011, 17:1668-1673.
76. Puche J.E., Lee Y.A., Jiao J., Aloman C., Fiel M.I., Munoz U., Kraus T., Lee T., Yee H.F., Friedman S.L. A novel murine model to deplete hepatic stellate cells uncovers their role in amplifying liver damage. Hepatology 2012, 57:339-350.
77. Coulouarn C., Corlu A., Glaise D., Guenon I., Thorgeirsson S.S., Clement B. Hepatocyte-stellate cell cross-talk in the liver engenders a permissive inflammatory microenvironment that drives progression in hepatocellular carcinoma. Cancer Res. 2012, 72:2533-2542.
78. Jhandier M.N., Kruglov E.A., Lavoie E.G., Sevigny J., Dranoff J.A. Portal fibroblasts regulate the proliferation of bile duct epithelia via expression of NTPDase2. J. Biol. Chem. 2005, 280:22986-22992.
79. Boulter L., Govaere O., Bird T.G., Radulescu S., Ramachandran P., Pellicoro A., Ridgway R.A., Seo S.S., Spee B., Van Rooijen N., Sansom O.J., Iredale J.P., Lowell S., Roskams T., Forbes S.J. Macrophage-derived Wnt opposes Notch signaling to specify hepatic progenitor cell fate in chronic liver disease. Nat. Med. 2012, 18:572-579.
80. Fingas C.D., Bronk S.F., Werneburg N.W., Mott J.L., Guicciardi M.E., Cazanave S.C., Mertens J.C., Sirica A.E., Gores G.J. Myofibroblast-derived PDGF-BB promotes hedgehog survival signaling in cholangiocarcinoma cells. Hepatology 2011, 54:2076-2088.
81. Iredale J.P., Benyon R.C., Pickering J., McCullen M., Northrop M., Pawley S., Hovell C., Arthur M.J. Mechanisms of spontaneous resolution of rat liver fibrosis. Hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors. J. Clin. Invest. 1998, 102:538-549.
82. Krizhanovsky V., Yon M., Dickins R.A., Hearn S., Simon J., Miething C., Yee H., Zender L., Lowe S.W. Senescence of activated stellate cells limits liver fibrosis. Cell 2008, 134:657-667.
83. Hecker L., Jagirdar R., Jin T., Thannickal V.J. Reversible differentiation of myofibroblasts by MyoD. Exp. Cell Res. 2011, 317:1914-1921.
84. Wang H., Haeger S.M., Kloxin A.M., Leinwand L.A., Anseth K.S. Redirecting valvular myofibroblasts into dormant fibroblasts through light-mediated reduction in substrate modulus. PLoS One 2012, 7:e39969.
85. Sohara N., Znoyko I., Levy M.T., Trojanowska M., Reuben A. Reversal of activation of human myofibroblast-like cells by culture on a basement membrane-like substrate. J. Hepatol. 2002, 37:214-221.
86. She H., Xiong S., Hazra S., Tsukamoto H. Adipogenic transcriptional regulation of hepatic stellate cells. J. Biol. Chem. 2005, 280:4959-4967.
87. Kisseleva T., Cong M., Paik Y., Scholten D., Jiang C., Benner C., Iwaisako K., Moore-Morris T., Scott B., Tsukamoto H., Evans S.M., Dillmann W., Glass C.K., Brenner D.A. Myofibroblasts revert to an inactive phenotype during regression of liver fibrosis. Proc. Natl. Acad. Sci. U. S. A. 2012, 109:9448-9453.
88. Troeger J.S., Mederacke I., Gwak G.Y., Dapito D.H., Mu X., Hsu C.C., Pradere J.P., Friedman R.A., Schwabe R.F. Deactivation of hepatic stellate cells during liver fibrosis resolution in mice. Gastroenterology 2012, 143:1073-1083. (e1022).
89. D'Ambrosio R., Aghemo A., Rumi M.G., Ronchi G., Donato M.F., Paradis V., Colombo M., Bedossa P. A morphometric and immunohistochemical study to assess the benefit of a sustained virological response in hepatitis C virus patients with cirrhosis. Hepatology 2012, 56:532-543.
90. Wright M.C., Issa R., Smart D.E., Trim N., Murray G.I., Primrose J.N., Arthur M.J., Iredale J.P., Mann D.A. Gliotoxin stimulates the apoptosis of human and rat hepatic stellate cells and enhances the resolution of liver fibrosis in rats. Gastroenterology 2001, 121:685-698.
91. Kobold D., Grundmann A., Piscaglia F., Eisenbach C., Neubauer K., Steffgen J., Ramadori G., Knittel T. Expression of reelin in hepatic stellate cells and during hepatic tissue repair: a novel marker for the differentiation of HSC from other liver myofibroblasts. J. Hepatol. 2002, 36:607-613.
92. Lepreux S., Bioulac-Sage P., Gabbiani G., Sapin V., Housset C., Rosenbaum J., Balabaud C., Desmouliere A. Cellular retinol-binding protein-1 expression in normal and fibrotic/cirrhotic human liver: different patterns of expression in hepatic stellate cells and (myo)fibroblast subpopulations. J. Hepatol. 2004, 40:774-780.
93. Dudas J., Mansuroglu T., Batusic D., Ramadori G. Thy-1 is expressed in myofibroblasts but not found in hepatic stellate cells following liver injury. Histochem. Cell Biol. 2009, 131:115-127.
94. Ogawa T., Tateno C., Asahina K., Fujii H., Kawada N., Obara M., Yoshizato K. Identification of vitamin A-free cells in a stellate cell-enriched fraction of normal rat liver as myofibroblasts. Histochem. Cell Biol. 2007, 127:161-174.
95. Thabut D., Shah V. Intrahepatic angiogenesis and sinusoidal remodeling in chronic liver disease: new targets for the treatment of portal hypertension?. J. Hepatol. 2010, 53:976-980.